Williams GH - Search Results

1

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.

Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL. Williams GH, et al. Am J Cardiol. 2004 Apr 15;93(8):990-6. doi: 10.1016/j.amjcard.2004.01.007. Am J Cardiol. 2004. PMID: 15081441 Clinical Trial.

2

Prolonged converting enzyme inhibition in non-modulating hypertension.

Dluhy RG, Smith K, Taylor T, Hollenberg NK, Williams GH. Dluhy RG, et al. Among authors: williams gh. Hypertension. 1989 Apr;13(4):371-7. doi: 10.1161/01.hyp.13.4.371. Hypertension. 1989. PMID: 2538393

3

Sodium-sensitive essential hypertension: emerging insights into an old entity.

Williams GH, Hollenberg NK. Williams GH, et al. J Am Coll Nutr. 1989 Dec;8(6):490-4. doi: 10.1080/07315724.1989.10720318. J Am Coll Nutr. 1989. PMID: 2695548 Review.

4

Metabolic derangements in nonmodulating hypertension.

Gaboury CL, Hollenberg NK, Hopkins PN, Williams R, Williams GH. Gaboury CL, et al. Among authors: williams gh, williams r. Am J Hypertens. 1995 Sep;8(9):870-5. doi: 10.1016/0895-7061(95)00160-Q. Am J Hypertens. 1995. PMID: 8541001

5

The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.

Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK. Price DA, et al. Among authors: williams gh. Am J Hypertens. 1999 Apr;12(4 Pt 1):348-55. Am J Hypertens. 1999. PMID: 10232494 Clinical Trial.

6

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.

Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK. Rocha R, et al. Among authors: williams gh. Endocrinology. 2000 Oct;141(10):3871-8. doi: 10.1210/endo.141.10.7711. Endocrinology. 2000. PMID: 11014244

7

Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.

Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. Martinez DV, et al. Among authors: williams gh. Hypertension. 2002 Feb;39(2 Pt 2):614-8. Hypertension. 2002. PMID: 11882618

8

Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.

Hollenberg NK, Williams GH, Anderson R, Akhras KS, Bittman RM, Krause SL. Hollenberg NK, et al. Among authors: williams gh. Arch Intern Med. 2003 Jul 14;163(13):1543-8. doi: 10.1001/archinte.163.13.1543. Arch Intern Med. 2003. PMID: 12860576 Clinical Trial.

9

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.

Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. Pitt B, et al. Among authors: williams gh. Circulation. 2003 Oct 14;108(15):1831-8. doi: 10.1161/01.CIR.0000091405.00772.6E. Epub 2003 Sep 29. Circulation. 2003. PMID: 14517164 Clinical Trial.

10

Mineralocorticoid receptor antagonists and hypertension: is there a rationale?

Gumieniak O, Williams GH. Gumieniak O, et al. Among authors: williams gh. Curr Hypertens Rep. 2004 Aug;6(4):279-87. doi: 10.1007/s11906-004-0022-8. Curr Hypertens Rep. 2004. PMID: 15257862 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters